Deccan Health Care Ltd Q4 FY26 Results

Summary

Deccan Health Care Limited delivered a strong performance for FY 2025-26, with standalone revenue from operations increasing by 18.7% to ₹8,917.10 Lakhs. Profit After Tax (PAT) surged by 91.2% to ₹229.04 Lakhs, reflecting enhanced operational efficiencies and improved margins, with the standalone net profit margin strengthening to 2.57%. Consolidated results also showed growth, with revenue up 9.1% to ₹8,190.48 Lakhs and PAT increasing by 114.7% to ₹248.76 Lakhs. The company continues to focus on science-led innovation, quality manufacturing, and expanding its diversified portfolio and market reach through various channels.

Key Highlights

1. 1

   Deccan Health Care Limited achieved an 18.7% year-on-year growth in standalone revenue from operations, which reached ₹8,917.10 Lakhs for FY 2025-26.

2. 2

   Standalone Profit After Tax (PAT) recorded a substantial increase of 91.2%, amounting to ₹229.04 Lakhs for FY 2025-26.

3. 3

   The company reported a standalone EBITDA growth of 46.7% for FY 2025-26, indicating improved operational performance.

4. 4

   Earnings Per Share (EPS) for standalone operations grew by 66.1% to ₹0.93 in FY 2025-26 from ₹0.56 in the prior year.

5. 5

   The company significantly improved its standalone net profit margin from 1.59% in FY 2024-25 to 2.57% in FY 2025-26, highlighting strengthening profitability.

6. 6

   Consolidated revenue from operations increased by 9.1% to ₹8,190.48 Lakhs, and consolidated Profit After Tax (PAT) saw a remarkable 114.7% jump to ₹248.76 Lakhs.

7. 7

   Deccan Health Care is strategically expanding its consumer reach through global exports, a pan-India network of Wellness Marts, leading e-commerce platforms, private label partnerships, and direct-to-consumer channels.